U.S. Food and Drug Administration (FDA) adds a Boxed Warning for added risk of mortality from gout prescription drug Uloric (febuxostat)

U.S. Food and Drug Administration (FDA) adds a Boxed Warning for added risk of mortality from gout prescription drug Uloric (febuxostat)

conduct a large postmarket safety clinical trial. uloric heart attack was conducted in more than 6,000 patients with gout treated with either Uloric or allopurinol. The main result was a combination of heart-related death, non-deadly heart attack, non-deadly stroke, and a condition of inadequate blood supply to the heart requiring intervention, called unstable angina.

 

Does Your Case Qualify for a Lawsuit Against the Makers of Uloric? According to new Black Box warnings mandated by the FDA, use of Uloric can elevate the risk of suffering one of the following conditions:

 

Death

 

Heart Attack

 

Stroke

 

Pulmonary Embolism (PE)

 

Deep Vein Thrombosis (DVT)

 

If you or a loved one has experienced any of the above while using Uloric for the treatment of gout, you might be entitled to a settlement from Takeda Pharmaceuticals, as well as for expenses, emotional distress, and inconveniences that you have endured as a result of your medical treatment.

 

The attorneys at The Meneo Law Group not only have the skill, experience, and knowledge to handle your Uloric lawsuit, but a proven track record of success in representing people, like you, that have been harmed by dangerous medications and products.